Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, [...]
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, [...]
NICE tells Gilead to cut Trodelvy’s price and rejects eczema [...]
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex [...]
Biogen’s troubled Aduhelm hit with CMS slapdown—now what? aliu Fri, [...]
AbbVie’s Rinvoq rockets up the pharma TV ad chart in [...]
CMS sticks to its guns, limiting coverage of Biogen’s Aduhelm [...]
Despite TV ads, most asthma patients don’t recognize new biologic [...]
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers [...]
AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential [...]
Amgen gives CEO a pay bump despite its eventful year [...]